SynCo Bio Partners Signs New Manufacturing Agreements to Supply the US Market; Securing its Position as a Market Leader in Microbial Biopharmaceutical Contract Production
By Synco Bio Partners B.v., PRNE
February 1st, 2010
AMSTERDAM, February 2 - SynCo Bio Partners B.V. today announced that it has signed two
commercial manufacturing agreements with an undisclosed US biopharmaceutical
company. Under the contract, SynCo will provide both process validation and
GMP commercial manufacturing services to support the commercial launch of two
separate biopharmaceutical products onto the US market.
SynCo has commenced with preparations for the manufacture of
conformance lots in advance of its client's BLA filings, expected in late
2010, in anticipation of commercial manufacturing commencing in 2011.
The products are both recombinant proteins, to be produced in
E. coli. These products will be manufactured in SynCo's large-scale GMP
facility and take the tally of marketed products manufactured at its
Amsterdam facilities to six, since SynCo's inception in 2000. SynCo has
previously supported process development efforts for both products; an
excellent example of how SynCo supports its clients' biopharmaceutical
development programs from early stage to commercial supply.
Pierre Warffemius, CEO of SynCo Bio Partners said, "This news
is a further example of how SynCo can offer a viable long-term manufacturing
choice to its clients. SynCo has grown steadily over the last ten years in a
very competitive market. The foundation of this growth has been our ability
to form strong and mutually beneficial relationships with our clients. As a
consequence, SynCo is one of few biopharmaceutical CMOs in the world with a
recognized track record in both clinical and commercial manufacturing,
providing financial stability that allows us to continuously invest in our
facilities."
About SynCo Bio Partners B.V.
SynCo Bio Partners is a GMP-licensed bulk drug substance and
final product CMO with clinical and commercial production experience in
mammalian and microbial systems. This experience has been acquired by
developing new production processes for a number of international clients and
producing a wide variety of vaccines, recombinant proteins and live bacterial
products in our state-of-the-art, GMP-licensed facilities since inception in
2000.
Focused solely on biopharmaceuticals, SynCo acts as a
strategic, long-term partner delivering product on time to the highest
quality standards. SynCo's team is committed to exceeding customer
expectations, taking a truly collaborative approach to contract
manufacturing.
For more information, please visit www.syncobiopartners.com
For more information, please contact: SynCo Bio Partners B.V., Joanne McCudden PhD, +31-6-5534-8074, J.mccudden at syncobiopartners.com
Filed under Biotechnology, Business, Contracts, Health, Investors, New Products / Services, Pharmaceuticals | Tags: Amsterdam, Netherlands, SynCo Bio Partners B.V. | Comment Below
Related Press Releases Nexans Wins 100 Million Euros Power Cable contract for the London Array Project, the World's Largest Offshore Wind FarmDecember 13th, 2009 PARIS, December 14 - Nexans, the worldwide leader in the cable industry, has won a
contract worth approximately 100 million Euros to design, manufacture and
supply the high voltage (HV) subsea power export cables that will connect the
London Array wind farm to the UK grid. The London Array wind farm is being installed on a 233 km2
site located around 20 km off the UK coast, in the Thames Estuary. Freescale Semiconductor Appoints ATREG as Advisor for Two Operational Fab SalesNovember 8th, 2009 SEATTLE -
ATREG, the semiconductor division of Colliers International, announced their formal appointment as advisor to Freescale Semiconductor, in the sale of two of Freescale's operational 150mm semiconductor manufacturing facilities. The automotive qualified analog fab offerings are located in Toulouse, France and Sendai, Japan, and include complete process tool lines and wafer supply agreements. Technology Company IAI Industrial Systems Will Supply a BookMaster One System for Passport Personalisation to PolandOctober 5th, 2009 WAALWIJK, Netherlands - Technology company IAI industrial systems in Veldhoven, the Netherlands, a subsidiary of the stock listed company DOCDATA N.V. in Waalwijk, the Netherlands, will supply a BookMaster One system for personalisation of passports to Poland. SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical CompanyAugust 31st, 2009 AMSTERDAM - SynCo Bio Partners B.V., the expert in long term GMP contract manufacturing of biopharmaceuticals announced today that it has expanded its business into a new geographical market, with the signing of a contract to manufacture a live biotherapeutic for an emerging Japanese pharmaceutical company. The undisclosed company's product is an innovative live biotherapeutic based anticancer drug. Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences(R) to Provide World-Class Fluid Management and Liquid/Powder System SolutionsJuly 13th, 2009 GOETTINGEN, Germany and ST. LOUIS -
- Global agreement strengthens customized manufacturing solutions for upstream and downstream processing and moves the 'disposable factory' closer to reality
Sartorius Stedim Biotech (Euronext: DIM), and SAFC Biosciences, a business segment of SAFC and member of the Sigma-Aldrich group (Nasdaq: SIAL), both leading suppliers to the biopharmaceutical industry, announced the signing of a global partnership agreement that combines Sartorius Stedim Biotech's (SSB) expertise in filtration and liquid handling systems with SAFC Biosciences' proficiency in development and manufacturing of cell culture media and downstream purification products. Novasep Acquires Bioprocess Development Specialist and Contract Manufacturer HenogenJuly 5th, 2009 POMPEY, France -
- Belgian Acquisition Means Novasep Offers Full-Range of Biomanufacturing Solutions
Novasep, a leading producer of active pharmaceutical ingredients (APIs) and purification technologies for the life science industries, announces today the acquisition of Henogen, a contract manufacturing organization (CMO) offering bioprocess development and manufacturing services from the cell bank to the supply of clinical products. The move adds a complementary, market-leading range of upstream processing capabilities and services to Novasep's comprehensive downstream processing (DSP) offer. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company OctapharmaApril 30th, 2009 LACHEN, Switzerland - Company Working With Authorities to Ensure Adequate Supply of Virally Inactivated Plasma Derivatives
The impending influenza pandemic will have implications for global stocks of life-saving blood and blood products, warns Swiss-based global biopharmaceutical company, Octapharma. But it has reiterated the safety of its plasma derivatives and is working closely with health authorities and plasma suppliers to maintain the safety profile and continuous supply of its lifesaving products. SynCo Bio Partners Wins Best Contract Manufacturing Organization 2009 ViE AwardApril 29th, 2009 AMSTERDAM - SynCo Bio Partners B.V. (Amsterdam, The Netherlands), the cGMP manufacturer of clinical and commercial biopharmaceuticals, has won the Vaccine Industry Excellence (ViE) award for Best Contract Manufacturing Organization (CMO) 2009. Mycosafe and ViruSure: Two Austrian Biosafety Companies Expand to AsiaMarch 18th, 2009 VIENNA, Austria and SINGAPORE - Mycoplasma biosafety specialist Mycosafe Diagnostics GmbH and virus and
prion biosafety company ViruSure GmbH - both based in Vienna, Austria - today
announced at BioMedical Asia 2009 that they are to establish a second site in
Singapore as part of a joint venture. This move will ensure that both
companies are in an ideal position to offer the biosafety expertise and
laboratory services so urgently required in the rapidly-expanding
biopharmaceutical and biotechnology industry in Asia. Signs That Employers opt for Alternatives to RedundancyMarch 15th, 2009 DUBLIN - Eurofound Maps Employment Measures at Company and Member State Level
in Europe:
There are signs that EU governments and companies are opting for
employment-maintaining initiatives, as opposed to redundancies and lay-offs,
as they look to ride out the storm of the current financial chaos. A new
report from Eurofound, the Dublin-based EU agency maps innovative and good
practice government and company measures to keep workers in employment.
Related News Business leaders optimistic about Midwest, Plains economy, despite signs of weak recoveryJanuary 4th, 2010 Those surveyed optimistic about Midwest economyOMAHA, Neb. — Middle America's business sector appears optimistic about the region's economy over next six months, despite signs that suggest the economy will see a weak recovery in 2010, according to a survey of business leaders and supply managers in nine Midwest and Plains states released Monday. Swiss drug maker Novartis says it will buy US biopharmaceutical Corthera for $120MDecember 23rd, 2009 Novartis to buy US firm Corthera for $120 mlnBASEL, Switzerland — Swiss pharmaceuticals maker Novartis AG said Wednesday it will buy U.S. biopharmaceutical company Corthera Inc. General Electric receives $1.4 billion contract to supply turbines to wind farm projectDecember 10th, 2009 GE gets $1.4B pact to supply wind farm turbinesNEW YORK — General Electric Co. on Thursday said it has received a $1.4 billion contract to supply wind turbines and related services for a wind farm project that is expected to be the largest ever. ONGC to develop gas fields in IranDecember 2nd, 2009 NEW DELHI - The state-run oil explorer Oil and Natural Gas Corp (ONGC) and its partners have signed two agreements with Iranian authorities to develop gas fields in that country. The agreements were signed during Iranian Deputy Oil Minister Seifollah Jashnsaz's India visit Dec 1. Oil hangs below $74 as investors eye OPEC meeting, compliance with output quotasDecember 22nd, 2009 Oil hangs below $74 amid OPEC supply decisionSINGAPORE — Oil prices hung below $74 a barrel Tuesday in Asia as traders anticipated OPEC will leave crude production levels unchanged at the group's meeting later in the day. Benchmark crude for February delivery was up 4 cents to $73.76 at midday Singapore time in electronic trading on the New York Mercantile Exchange. Oil hangs near $74 as investors eye OPEC meeting, compliance with output quotasDecember 22nd, 2009 Oil hangs near $74 amid OPEC supply decisionSINGAPORE — Oil prices hung near $74 a barrel Tuesday in Asia as traders anticipated OPEC will leave crude production levels unchanged at the group's meeting later in the day. Benchmark crude for February delivery was up 21 cents to $73.93 at late afternoon Singapore time in electronic trading on the New York Mercantile Exchange. Audit of Reliance Industries gas fields soon: MinisterDecember 15th, 2009 NEW DELHI - The Comptroller and Auditor General of India will examine the contract between Mukesh Ambani's Reliance Industries and the government in respect of the Krishna-Godavari gas fields, the Rajya Sabha was informed Tuesday. The audit of the production-sharing contract would be for two years ended March 31, 2008, and will pertain to what has been named Block KG DWN-983, awarded to the Mukesh Ambani-led company, Minister of State for Petroleum and Natural Gas Jitin Prasada said. A trade group says manufacturing activity expanded faster than expected in DecemberJanuary 4th, 2010 Manufacturing grew faster than expected in Dec.WASHINGTON — Manufacturing activity grew last month at the fastest pace in more than three years, a sign that the pace of the economic recovery is picking up, a private trade group said Monday. The Institute for Supply Management, a trade group of purchasing executives, said its manufacturing index read 55.9 in December after 53.6 in November. Summary Box: Homes, construction, manufacturing data show moderate recovery continuesDecember 1st, 2009 Summary Box: Homes, manufacturing data point upMANUFACTURING REBOUND: The Institute for Supply Management's manufacturing index showed slower growth in November, but new orders jumped. That means factories are more likely to boost production in the months ahead. AT&T, labor union reach tentative contract agreement for thousands of AT&T employeesDecember 14th, 2009 AT&T, labor union reach tentative contract dealDALLAS — AT&T Inc. said Monday that it came to a tentative agreement in wireline contract negotiations with the Communications Workers of America in AT&T's southeast region, which includes 30,000 employees.
|
|
